Bausch Health Co. Inc. (BHC) Misses Q4 EPS by 201c

Bausch Health Co. Inc. (NYSE: BHC) reported Q4 EPS of ($1.13), $2.01 worse than the analyst estimate of $0.88. Revenue for the quarter came in at $2.19 billion versus the consensus estimate of $2.14 billion.

For earnings history and earnings-related data on Bausch Health Co. Inc. (BHC) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• TSX miners rally as precious metals stocks dominate top gainers
• Bausch + Lomb Announces New Published Research on enVista Aspire™ Real World Experience